Articles

  • Jan 31, 2024 | cell.com | Wenjun Xia |Peng Jiang

    Highlights•Loss of p53 impairs antiviral innate immunity•p53 drives HBP and protein O-GlcNAcylation following VSV infection•UBXN1 O-GlcNAcylation promotes TBK1-IRF3-IFN-β antiviral signaling•HBP activation is essential for p53-mediated antiviral immune responsesSummaryThe tumor suppressor p53 controls cell fate decisions and prevents malignant transformation, but its functions in antiviral immunity remain unclear.

Contact details

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →